Shilanski & Associates’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,713
Closed -$339K 112
2024
Q1
$339K Sell
1,713
-500
-23% -$91.4K 0.12% 73
2023
Q4
$385K Hold
2,213
0.15% 67
2023
Q3
$346K Hold
2,213
0.14% 74
2023
Q2
$363K Sell
2,213
-20
-0.9% -$2.92K 0.15% 76
2023
Q1
$320K Buy
2,233
+20
+0.9% +$3.18K 0.14% 76
2022
Q4
$292K Buy
+2,213
New +$301K 0.13% 87
2022
Q3
Sell
-2,213
Closed -$231K 192
2022
Q2
$231K Sell
2,213
-3
-0.1% -$406 0.11% 92
2022
Q1
$329K Sell
2,216
-1
-0% -$123 0.14% 86
2021
Q4
$253K Buy
2,217
+4
+0.2% +$437 0.11% 93
2021
Q3
$218K Hold
2,213
0.1% 99
2021
Q2
$212K Buy
+2,213
New +$207K 0.1% 102

Other funds holding NUE

Shilanski & Associates's NUE Position: Q2 2024 in Review

Shilanski & Associates sold out of Nucor (NUE) in Q2 2024, closing a stake of 1,713 shares — an estimated $339K sold.

Shilanski & Associates first reported a position in NUE in Q2 2021 and held it in 11 quarters. The position peaked at $385K in Q4 2023. 1,232 funds tracked by Wall St. Rank hold NUE as of Q2 2024.

  • Shilanski & Associates reported no remaining Nucor position as of Q2 2024 after selling out during the quarter.
  • Shilanski & Associates sold 1,713 Nucor shares in Q2 2024, an estimated $339K.
  • Shilanski & Associates first reported a position in Nucor in Q2 2021 and held it in 11 quarters.
  • Shilanski & Associates's Nucor position peaked at $385K in Q4 2023.
  • 1,232 funds tracked by Wall St. Rank held Nucor as of Q2 2024.

Based on Shilanski & Associates's 13F filing for Q2 2024, filed 18 Jul 2024.